Oncorus CEO, CFO resign; sole director Jalbert takes all officer roles; dissolution vote adjourned to Aug 18

Oncorus, Inc.

Brian Shea resigned as President, Interim CEO, General Counsel, Secretary; Alexander Nolte resigned as Interim CFO, Treasurer; both effective Aug 4.
Craig Jalbert, sole remaining director, appointed himself CEO, President, CFO, Treasurer, Secretary effective Aug 4.
Special meeting for dissolution plan adjourned three times due to lack of quorum; next meeting Aug 18, 2023 at 9am ET.
As of June 8, 2023, Oncorus had 26,094,847 shares outstanding; only 12,377,132 shares present at Aug 3 meeting.
Companies continues to solicit votes on dissolution proposals; stockholders encouraged to vote.

item 5.02 item 5.07 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Alexander Nolte

Interim Chief Financial Officer and Treasurer

Oncorus, Inc.

Effective: 2023-08-04
Successor: Craig Jalbert
Filed: August 3, 2023, 7:59 PM ET

Alexander Nolte notified the Company of his resignation as Interim Chief Financial Officer and Treasurer, effective as of the close of business Eastern Time on August 4, 2023.

Departed (interim)

Brian J. Shea

President and Interim Chief Executive Officer, as well as General Counsel and Secretary

Oncorus, Inc.

Effective: 2023-08-04
Successor: Craig Jalbert
Filed: August 3, 2023, 7:59 PM ET

Brian J. Shea notified Oncorus, Inc. (the " Company ") of his resignation as President and Interim Chief Executive Officer, as well as General Counsel and Secretary, effective as of the close of business Eastern Time on August 4, 2023.

Appointed

Craig Jalbert

Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary

Oncorus, Inc.

Effective: 2023-08-04
Filed: August 3, 2023, 7:59 PM ET

Craig Jalbert, in his capacity as the Company's sole remaining director, appointed himself as the Company’s Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary, effective as of the resignations of Mr. Shea and Mr. Nolte.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alexander Nolte resigned as Interim Chief Financial Officer and Treasurer at Oncorus, Inc..

Action: resigned
Role: Interim Chief Financial Officer and Treasurer

Exact text from the filing

Alexander Nolte notified the Company of his resignation as Interim Chief Financial Officer and Treasurer, effective as of the close of business Eastern Time on August 4, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian J. Shea resigned as President and Interim Chief Executive Officer, as well as General Counsel and Secretary at Oncorus, Inc..

Action: resigned
Role: President and Interim Chief Executive Officer, as well as General Counsel and Secretary

Exact text from the filing

Brian J. Shea notified Oncorus, Inc. (the " Company ") of his resignation as President and Interim Chief Executive Officer, as well as General Counsel and Secretary, effective as of the close of business Eastern Time on August 4, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Craig Jalbert was appointed as Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary at Oncorus, Inc..

Action: appointed
Role: Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary

Exact text from the filing

Craig Jalbert, in his capacity as the Company's sole remaining director, appointed himself as the Company’s Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary, effective as of the resignations of Mr. Shea and Mr. Nolte.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-23-038095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.